Red Violet, Inc. (RDVT)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$72.12-9.85%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
QuarterlyIQ Insights · RDVT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 103.7 | 90.3 | 75.2 | 60.2 | 53.3 | 44.0 | 34.6 | 30.3 | 16.3 |
| Total Revenues | 103.7 | 90.3 | 75.2 | — | — | — | — | — | — |
| Operating Expenses & Income | |||||||||
| Operating Income | 18.9 | 13.1 | 7.9 | 2.5 | 0.4 | (1.3) | (6.8) | (11.2) | (7.5) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.0 | — | — |
| EBT, Incl. Unusual Items | 21.1 | 14.6 | 9.3 | 3.8 | 0.7 | 0.9 | (6.8) | (11.1) | (6.9) |
| Income Tax Expense | 3.5 | 1.4 | 2.3 | (9.7) | 0.1 | 0.2 | — | — | — |
| Net Income | |||||||||
| Net Income | 17.6 | 13.2 | 7.0 | 13.5 | 0.6 | 0.7 | (6.8) | (11.1) | (6.9) |
| Per Share | |||||||||
| Basic EPS | 1.15 | 0.94 | 0.51 | 0.97 | 0.04 | 0.05 | — | — | — |
| Diluted EPS | 1.12 | 0.91 | 0.50 | 0.96 | 0.04 | 0.05 | — | — | — |
| Revenue per Share | 6.58 | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | 0.30 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 15.3 | 14.0 | 13.9 | 14.0 | 13.8 | 12.6 | — | — | — |
| Diluted Weighted Avg Shares | 15.8 | 14.4 | 14.1 | 14.1 | 14.1 | 13.4 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | 23.8 | 17.5 | 10.9 | 7.0 | 4.1 | (2.6) | (8.3) | (5.5) |
| EBIT | 18.9 | 13.1 | 7.9 | 2.5 | 0.4 | (1.3) | (6.8) | (11.2) | (7.5) |
| Effective Tax Rate | 16.5% | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.